EPAM: A Discount, or Just Delayed Pain?

by

Right. EPAM Systems. Shares took a proper tumble this week – down 16.4%, if you’re keeping score. And honestly, I’m starting to think my gut was right to be cautious. It’s always the quiet ones, isn’t it? They look solid, report decent numbers… and then, bam. Reality hits. Data from S&P Global Market Intelligence confirms the damage, of course, but numbers don’t tell you the feeling. The sheer, unadulterated panic that starts to creep in.

They reported earnings on Thursday, beat expectations on both top and bottom lines. Textbook stuff. But the market? The market doesn’t do textbooks. It wants fireworks. It got… a polite cough. Investors fixated on the 2026 guidance. Which, let’s be honest, was less “growth trajectory” and more “gentle deceleration.” It’s like watching a perfectly good car slowly roll backwards down a hill. You know it’s going to end badly.

So, here we are. The stock is cheap. Very cheap. But is it an opportunity? Or are we looking at a value trap so exquisitely crafted it’ll take years to escape? That’s the question, isn’t it? The one that keeps me awake at 3 AM, re-running scenarios, questioning every assumption. Because let’s be real, in this game, hope isn’t a strategy.

Loading widget...

The AI Elephant in the Room (and My Portfolio)

Okay, the numbers. Q4 revenue was up 12.8% to $1.41 billion, adjusted EPS up 14.8% to $3.26. Not bad. Not amazing. And here’s the kicker: a good chunk of that growth came from acquisitions. Strip those out, and the organic growth rate drops to a measly 5.6% in Q4, 4.9% for the year. They’re buying growth, basically. It’s like putting a bandage on a gaping wound and hoping no one notices.

And the 2026 guidance? Revenue growth between 4.5% and 7.5%, organic growth between 3% and 6%. A slowdown. A definite, undeniable slowdown. And everyone’s pretending it’s not happening. Management insists it’s not AI-related. Just enterprises “taking their time” with IT plans. Oh, sure. They’re taking their time. While robots are quietly plotting to take all our jobs. I’m just saying, it’s a possibility.

Apparently, their largest client at NOERIS, a consulting firm they bought last year, is scaling back. That’s going to shave a full percentage point off their 2026 growth rate. A lovely little surprise. Honestly, acquisitions always feel like a gamble to me. It’s like bringing a stray dog into your house and hoping it doesn’t eat the furniture. Sometimes it works out. Sometimes it doesn’t.

Cheap, But At What Cost?

At $139 a share, EPAM trades at just under 11 times this year’s adjusted EPS. It looks cheap. Dangerously cheap. But a lot of consulting firms are trading at low valuations right now. Everyone’s terrified of the AI boogeyman. And frankly, I get it. If AI can do the work of human consultants, these companies are in trouble. Big trouble.

Management teams are, predictably, downplaying the threat. “We’re not seeing any impact,” they say. Right. And I’m not addicted to caffeine. Look, I’m not saying they’re lying. But I am saying they have a vested interest in presenting a rosy picture. It’s what they’re paid to do. The question is, will AI disrupt this industry in the next year, two years, five years? If it does, this stock could be a disaster. If it doesn’t… well, we might have a bargain on our hands. It’s a coin toss, really. And I hate coin tosses.

Read More

2026-02-20 20:12